These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2850112)

  • 21. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis.
    Ioannou GN; Splan MF; Weiss NS; McDonald GB; Beretta L; Lee SP
    Clin Gastroenterol Hepatol; 2007 Aug; 5(8):938-45, 945.e1-4. PubMed ID: 17509946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relation between the pathologic grading and the distribution of HBAg in hepatocellular carcinoma].
    Wang WL
    Zhonghua Zhong Liu Za Zhi; 1983 Jan; 5(1):31-3. PubMed ID: 6189684
    [No Abstract]   [Full Text] [Related]  

  • 23. [The role of the hepatitis B virus in the development of liver cirrhosis and tumors].
    Shaff J; Lapish K
    Arkh Patol; 1988; 50(11):47-51. PubMed ID: 2852934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular study of the hepatic inflammation to fibrosis to cancer axis].
    Cai WM
    Zhonghua Gan Zang Bing Za Zhi; 2009 Oct; 17(10):799-800. PubMed ID: 19874704
    [No Abstract]   [Full Text] [Related]  

  • 25. [Primary hepatocellular carcinoma. Relation between serum and liver alpha fetoprotein, B virus infection, histology].
    Maggi G; Bighellini K; Borghi L
    Minerva Dietol Gastroenterol; 1985; 31(4):627-33. PubMed ID: 2418386
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hepatic cirrhosis with and without implanted carcinoma. Apropos of 100 cases with necropsy].
    Pérez Flores R; Cortés Cansino J; Oliva Aldamiz H; Hernández Guío C
    Rev Clin Esp; 1987 Nov; 181(7):356-60. PubMed ID: 2827249
    [No Abstract]   [Full Text] [Related]  

  • 27. Hepatitis B viral infection: part I. Clinical features.
    Dzik WH; Alter HJ
    Am Fam Physician; 1982 Aug; 26(2):119-26. PubMed ID: 6285684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Localization of HBsAg and HBcAg by peroxidase-labeled antibody].
    Hong SF
    Zhonghua Yi Xue Za Zhi; 1985 Jun; 65(6):352-4. PubMed ID: 2994857
    [No Abstract]   [Full Text] [Related]  

  • 29. Oncogenic potential of the hepatitis B virus.
    Trop Gastroenterol; 1983; 4(1):1-2. PubMed ID: 6306882
    [No Abstract]   [Full Text] [Related]  

  • 30. [Primary liver carcinoma and markers of virus of type B hepatitis (author's transl)].
    Pedreira JD; Vargas V; Vilaseca J; Esteban R; Hernández-Sánchez JM; Guardia J; Bacardi R
    Med Clin (Barc); 1980 Jun; 75(2):58-60. PubMed ID: 6249978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K; Pal NS; Arora SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Variable clinical symptoms of hepatocellular carcinoma].
    Struve C; Heusermann U
    Dtsch Med Wochenschr; 1988 Feb; 113(8):294-6. PubMed ID: 2449323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors and hepatocellular cancer.
    Yu MC; Henderson BE
    Lancet; 1985 Aug; 2(8450):329-30. PubMed ID: 2862491
    [No Abstract]   [Full Text] [Related]  

  • 34. HBeAg/anti-HBe system and development of primary hepatocellular carcinoma in patients with HBsAg-positive liver cirrhosis.
    Musca A; Cordova C; Barnaba V; Bonavita MS; Levrero M; Zaccari C; Balsano F
    Hepatogastroenterology; 1983 Feb; 30(1):3-5. PubMed ID: 6299916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications.
    Hui CK; Leung N; Shek WH; Zhang HY; Luk JM; Poon RT; Lo CM; Fan ST; Lau GK;
    J Clin Gastroenterol; 2008; 42(5):533-8. PubMed ID: 18344885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Primary hepatocarcinoma and hepatitis B virus in Sardinia].
    Lai ME; Faa G; Farci P; Liguori C; Figus A; Costa V; Balestrieri A
    Pathologica; 1988; 80(1068):443-8. PubMed ID: 2854232
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hepatitis B virus infection: current developments].
    van Ditzhuysen JM; van Loon AM; Yap SH
    Ned Tijdschr Geneeskd; 1983 Nov; 127(48):2193-8. PubMed ID: 6318129
    [No Abstract]   [Full Text] [Related]  

  • 38. Risk factors for hepatocellular carcinoma.
    Lai CL; Lok A; Wu PC; Ng M
    Lancet; 1985 Sep; 2(8454):552-3. PubMed ID: 2863566
    [No Abstract]   [Full Text] [Related]  

  • 39. [Current approach to hepatic carcinogenesis. From cirrhosis to hepatocellular carcinoma].
    Le Bail B; Bioulac-Sage P; Tran van Nhieu J; Zafrani ES
    Ann Pathol; 1995; 15(5):332-47. PubMed ID: 8540919
    [No Abstract]   [Full Text] [Related]  

  • 40. [Neoplastic degeneration of liver cirrhosis: comments on personal cases].
    Giuliani-Piccari G; Dal Monte PR
    G Clin Med; 1982 Oct; 63(10):731-6. PubMed ID: 6303881
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.